149 related articles for article (PubMed ID: 20936377)
21. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
22. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
[TBL] [Abstract][Full Text] [Related]
24. Kindlin-2: a novel prognostic biomarker for patients with hepatocellular carcinoma.
Ge YS; Liu D; Jia WD; Li JS; Ma JL; Yu JH; Xu GL
Pathol Res Pract; 2015 Mar; 211(3):198-202. PubMed ID: 25618552
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jung HI; Jeong D; Ji S; Ahn TS; Bae SH; Chin S; Chung JC; Kim HC; Lee MS; Baek MJ
Cancer Res Treat; 2017 Jan; 49(1):246-254. PubMed ID: 27456947
[TBL] [Abstract][Full Text] [Related]
26. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
27. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
[TBL] [Abstract][Full Text] [Related]
28. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
29. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
[TBL] [Abstract][Full Text] [Related]
30. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
31. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
32. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
34. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
35. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma.
Wang HJ; Wang L; Song SS; He XL; Pan HY; Hu ZM; Mou XZ
Cancer Biomark; 2018 Feb; 21(3):723-730. PubMed ID: 29278884
[TBL] [Abstract][Full Text] [Related]
38. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
40. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]